62.11 USD
-1.08 (-1.71%)
62.11 USD
0 (0%)
LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of LIVN get a neutral evaluation. Nothing too spectacular is happening here. LIVN is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
- LIVN had positive earnings in the past year.
- In the past year LIVN had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
- LIVN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- LIVN has a Return On Assets of -8.48%. This is in the better half of the industry: LIVN outperforms 63.78% of its industry peers.
- LIVN has a better Return On Equity (-18.76%) than 61.08% of its industry peers.
- LIVN has a better Return On Invested Capital (8.38%) than 85.95% of its industry peers.
- LIVN had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 8.84%.
- The last Return On Invested Capital (8.38%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROIC | 8.38% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 15.01%, LIVN belongs to the top of the industry, outperforming 83.24% of the companies in the same industry.
- In the last couple of years the Operating Margin of LIVN has grown nicely.
- The Gross Margin of LIVN (68.50%) is better than 74.59% of its industry peers.
- LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% |
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
- Compared to 1 year ago, LIVN has about the same amount of shares outstanding.
- Compared to 5 years ago, LIVN has more shares outstanding
- LIVN has a worse debt/assets ratio than last year.
2.2 Solvency
- LIVN has an Altman-Z score of 1.75. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
- LIVN has a Altman-Z score (1.75) which is comparable to the rest of the industry.
- The Debt to FCF ratio of LIVN is 2.26, which is a good value as it means it would take LIVN, 2.26 years of fcf income to pay off all of its debts.
- LIVN has a Debt to FCF ratio of 2.26. This is amongst the best in the industry. LIVN outperforms 86.49% of its industry peers.
- LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
- LIVN's Debt to Equity ratio of 0.30 is in line compared to the rest of the industry. LIVN outperforms 51.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Altman-Z | 1.75 |
ROIC/WACC0.97
WACC8.61%
2.3 Liquidity
- LIVN has a Current Ratio of 1.32. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of LIVN (1.32) is worse than 77.84% of its industry peers.
- A Quick Ratio of 1.12 indicates that LIVN should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.12, LIVN is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
- The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
- Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
- LIVN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.94% yearly.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
3.2 Future
- The Earnings Per Share is expected to grow by 13.20% on average over the next years. This is quite good.
- LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y16.72%
EPS Next 2Y11.94%
EPS Next 3Y10.66%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.71%
Revenue Next 3Y7.93%
Revenue Next 5Y7.67%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.13, which indicates a correct valuation of LIVN.
- Based on the Price/Earnings ratio, LIVN is valued cheaper than 87.57% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.47. LIVN is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 14.71, which indicates a correct valuation of LIVN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 89.73% of the companies listed in the same industry.
- LIVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.26.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.13 | ||
| Fwd PE | 14.71 |
4.2 Price Multiples
- 85.41% of the companies in the same industry are more expensive than LIVN, based on the Enterprise Value to EBITDA ratio.
- LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 91.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.67 | ||
| EV/EBITDA | 13.11 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.96
PEG (5Y)8.88
EPS Next 2Y11.94%
EPS Next 3Y10.66%
5. Dividend
5.1 Amount
- LIVN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
62.11
-1.08 (-1.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners105.72%
Inst Owner Change0%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.39B
Revenue(TTM)1.35B
Net Income(TTM)-217.00M
Analysts82.35
Price Target70.78 (13.96%)
Short Float %3.95%
Short Ratio3.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)2.45%
PT rev (3m)9.05%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-9.99%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.87%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.13 | ||
| Fwd PE | 14.71 | ||
| P/S | 2.51 | ||
| P/FCF | 17.67 | ||
| P/OCF | 13.51 | ||
| P/B | 2.93 | ||
| P/tB | 25.7 | ||
| EV/EBITDA | 13.11 |
EPS(TTM)3.85
EY6.2%
EPS(NY)4.22
Fwd EY6.8%
FCF(TTM)3.52
FCFY5.66%
OCF(TTM)4.6
OCFY7.4%
SpS24.7
BVpS21.2
TBVpS2.42
PEG (NY)0.96
PEG (5Y)8.88
Graham Number42.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROCE | 11.71% | ||
| ROIC | 8.38% | ||
| ROICexc | 13.38% | ||
| ROICexgc | 250.34% | ||
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% | ||
| FCFM | 14.23% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.41%
ROICexc growth 3Y38.4%
ROICexc growth 5Y24.59%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 132.77% | ||
| Cap/Sales | 4.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.75 |
F-Score6
WACC8.61%
ROIC/WACC0.97
Cap/Depr(3y)78.92%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.72%
EPS Next 2Y11.94%
EPS Next 3Y10.66%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.71%
Revenue Next 3Y7.93%
Revenue Next 5Y7.67%
EBIT growth 1Y51.48%
EBIT growth 3Y51.06%
EBIT growth 5Y22.44%
EBIT Next Year40.27%
EBIT Next 3Y17.98%
EBIT Next 5Y3.36%
FCF growth 1Y2168.7%
FCF growth 3Y20.84%
FCF growth 5YN/A
OCF growth 1Y532.9%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
Can you provide the valuation status for LIVANOVA PLC?
ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.
What is the profitability of LIVN stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the financial health of LIVANOVA PLC (LIVN) stock?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.
Can you provide the expected EPS growth for LIVN stock?
The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.72% in the next year.